CCL: MoKa 2.5 for pKa, tautomer, logP, logD and IEP modelling
- From: Simon Cross <simon:-:moldiscovery.com>
- Subject: CCL: MoKa 2.5 for pKa, tautomer, logP, logD and IEP
modelling
- Date: Tue, 21 Jan 2014 12:14:14 +0100
Sent to CCL by: Simon Cross [simon---moldiscovery.com]
Hi Everyone, just to let you know that we have released MoKa 2.5 for
pKa, tautomer, logP, logD and IEP modelling.
As with every version, many literature compounds have
been experimentally retested to improve our confidence in the models;
with this release 40 of the 55 models have been recomputed based on
this
new data.
Additionally, structural input has been improved to make it
more efficient and less affected by external factors; for
example, counterions are now automatically stripped during LogP-LogD
and
IEP calculations.
Recognized ionizable centres that are predicted with lower certainty
are
now shown, to enable users to see where they should focus their efforts
to improve the provided models. The molecule isoelectric point (IEP) is
now computed. Finally, the model training module Kibitzer is now
accessible command-line, enabling users to automate custom model
building as new company data is obtained.
More information about MoKa can be found here:
http://www.moldiscovery.com/soft_moka.php
Kind regards,
Simon
Dr. Simon Cross
Snr Scientist & Product Manager
Molecular Discovery Ltd
Email: simon[at]moldiscovery[dot]com
Molecular Discovery provides robust, high-quality and innovative
computational methods addressing pharmaceutical needs in the field of
drug discovery, including methods for virtual screening, lead
optimisation, ADME modelling and metabolism research.
Molecular Discovery software products offer calculation of accurate
Molecular Interaction Fields for structure-based design (GRID),
ligand-based and structure-based virtual screening (FLAP),
pharmacophore
elucidation (FLAP), metabolism prediction (MetaSite), metabolite
identification (Mass-MetaSite), scaffold hopping (SHOP), pKa prediction
(MoKa), 3D-QSAR modeling (FLAP, Pentacle) to improve efficiency in
modern drug discovery.
More information can be found on the main page:
http://www.moldiscovery.com